Month: February 2021

Newtek Business Services Corp. Declares First Quarter 2021 Dividend of $0.50 per Share

Written by Customer Service on February 23, 2021. Posted in Dividend Reports And Estimates.

BOCA RATON, Fla., Feb. 23, 2021 (GLOBE NEWSWIRE) — Newtek Business Services Corp., (NASDAQ: NEWT), an internally managed business development company (“BDC”), today announced that its Board of Directors declared a first quarter 2021 cash dividend of $0.501 per share. The first quarter 2021 dividend is payable on March 31, 2021 to shareholders of record as of March 22, 2021. The payment of the first quarter 2021 dividend would represent a 13.6% increase over the first quarter 2020 dividend of $0.44 per share, and a 25% increase over the first quarter 2019 dividend of $0.40 per share.Note regarding Dividend Payments: The Company’s Board of Directors expects to maintain a dividend policy with the objective of making quarterly distributions in an amount that approximates 90 – 100% of the Company’s annual taxable income....

Newtek Business Services Corp.’s CEO, Barry Sloane, Comments on the Declaration of Newtek’s First Quarter 2021 Dividend of $0.50 per Share

Written by Customer Service on February 23, 2021. Posted in Dividend Reports And Estimates.

BOCA RATON, Fla., Feb. 23, 2021 (GLOBE NEWSWIRE) — Newtek Business Services Corp., (NASDAQ: NEWT), an internally managed business development company (“BDC”), provides Newtek CEO’s, Barry Sloane, comments on the declaration of Newtek’s first quarter 2021 cash dividend of $0.501 per share.Barry Sloane, President, Chairman and CEO commented, “We are pleased to report that our board has declared a first quarter 2021 dividend of $0.50 per share, payable on March 31, 2021 to our shareholders of record as of March 22, 2021. This dividend would represent a 13.6% increase over our first quarter 2020 dividend, which was impacted by the pandemic, and a 25% increase over our first quarter 2019 dividend. We believe our business model leaves us well positioned to continue to capture market opportunities, and we continue to maintain a strong...

NaturalShrimp Signs Letter of Intent to Acquire Aquaculture Assets of Hydrenesis Aquaculture, LLC

Written by Customer Service on February 23, 2021. Posted in Mergers And Acquisitions.

– Assets to be Acquired for $12,500,000– Major Financing Announcement Forthcoming from NSIDallas, TX, Feb. 23, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — NaturalShrimp, Inc., an aquaculture Company, which has developed and patented the first commercially operational Recirculating Aquaculture System (RAS) for shrimp, announced today that it has signed a Letter of Intent (LOI) to acquire the aquaculture assets of Hydrenesis Aquaculture, LLC for $12,500,000, consisting of $5,500,000 in cash and the balance due in NSI common stock. The acquisition is expected to be accretive to earnings in fiscal year 2021.Gerald Easterling, CEO of NaturalShrimp added, “NaturalShrimp has been working with Hydrenesis since 2018 on several solutions for the industry with the team at Hydrenesis. We currently have trials on going in Norway...

Better Choice Company Announces Alex Vournas as Vice President of Supply Chain & Logistics

Written by Customer Service on February 23, 2021. Posted in Public Companies.

NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) — Better Choice Company (OTCQX: BTTR) (“Better Choice”) (the “Company”), an animal health and wellness company, announced today the appointment of Alex Vournas as Vice President of Supply Chain & Logistics.Alex Vournas is a highly accomplished Supply Chain professional who most recently was the Director of Supply Chain at Solid Gold Pet LLC, where he oversaw global distribution and logistics and was responsible for managing multiple international and domestic co-manufactures and warehouses, outsourced transportation and ordering logistics. Among many other top accomplishments, Alex was also responsible for managing the logistics related to the company’s significant expansion into Asia, which culminated in a sale of the business to Hong Kong based H&H Group in November 2020. In addition...

SCYNEXIS and Amplity Health Announce Agreement to Support the Anticipated U.S. Commercialization of BrexafemmeTM (Ibrexafungerp) for Vaginal Yeast Infections

Written by Customer Service on February 23, 2021. Posted in Public Companies.

Synergistic combination of Amplity’s proven commercial sales capabilities and SCYNEXIS’ internal medical, marketing, and strategic expertise will maximize Brexafemme’s commercial potential while preserving SCYNEXIS’ global rights to the drugAmplity to defer a portion of SCYNEXIS’ commercial launch expenses for the first two years in exchange for a performance-based success feeBrexafemme, the conditionally FDA-approved brand name for ibrexafungerp for vaginal yeast infections, is on track for anticipated June 2021 approval and H2:2021 launchSCYNEXIS in a strong financial position to execute on its plans with a projected cash runway into 2023JERSEY CITY, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant...

Chinook Therapeutics to Present at 3rd Annual Chronic Kidney Disease Drug Development (CKD3) Summit

Written by Customer Service on February 23, 2021. Posted in Public Companies.

Head of Renal Discovery and Translational Medicine, Andrew King, D.V.M., Ph.D., to Present on Atrasentan and Participate in Expert Panel Discussion on Executing Precision Medicine in Clinical TrialsVANCOUVER, British Columbia and SEATTLE, Feb. 23, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Andrew King, D.V.M., Ph.D., Head of Renal Discovery and Translational Medicine, will present on behalf of Chinook at the 3rd Annual Chronic Kidney Disease Drug Development (CKD3) Summit. Dr. King will deliver a presentation titled “Selective ETA receptor antagonist atrasentan for the treatment of primary glomerular diseases” on Thursday, March 4th at 10:00 am EST. Dr. King...

Silo Pharma to Present at Proactive’s One2One Virtual Investor Forum

Written by Customer Service on February 23, 2021. Posted in Public Companies.

Englewood Cliffs, NJ, Feb. 23, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders, announced today that Eric Weisblum, Chief Executive Officer will be presenting at Proactive’s One2One Virtual Investor Forum on Tuesday, February 23, at 1 p.m. EST.The Virtual One2One Investor Forum invitation will be sent to Proactive’s estimated 20,000 YouTube subscribers and will be broadcasted internationally.Mr. Weisblum’s presentation will be followed by a Q&A session and it will be published online.For more information or to register for this event please visit https://www.proactiveinvestors.com.au/register/event_details/322About...

Just Energy Group Inc. Reassures Texas Residential Electricity Customers That They Are Protected From Storm-Related Price Surges

Written by Customer Service on February 23, 2021. Posted in Public Companies.

Just Energy, Amigo Energy and Tara Energy Residential Customers Will See No Change to Their Electricity Rates on February BillsTORONTO, Feb. 23, 2021 (GLOBE NEWSWIRE) — Just Energy Group Inc. (TSX:JE; NYSE:JE) (“Just Energy” or the “Company”), a retail energy provider specializing in electricity and natural gas commodities, renewable energy options and carbon offsets, today made the following statement to reassure its residential customers in Texas that they are protected from higher energy rates on their February bills as a result of recent extreme weather (the “Weather Event”):“Whether customers know us as Just Energy, Amigo Energy or Tara Energy, we have been a proud part of Texas communities for many years, providing residential energy to hundreds of thousands of customers across the state,” said Scott Gahn, Just Energy’s President...

CUMULUS MEDIA Reports Operating Results for 2020

Written by Customer Service on February 23, 2021. Posted in Earnings Releases And Operating Results.

ATLANTA, Feb. 23, 2021 (GLOBE NEWSWIRE) — Cumulus Media Inc. (NASDAQ: CMLS) (the “Company,” “CUMULUS MEDIA,” “we,” “us,” or “our”) today announced operating results for the three months and year ended December 31, 2020.Mary G. Berner, President and Chief Executive Officer of CUMULUS MEDIA, said, “Given 2020’s extenuating circumstances, I am extremely proud of the Company’s performance and the efforts of the entire Cumulus team to meet the challenges posed by COVID-19. In the face of the pandemic, we maximized revenue performance, materially reduced expenses, generated cash through strong working capital management, and executed highly accretive divestitures that strengthened our balance sheet. As a result of these efforts and with a recovering economy, we believe that we are well-positioned to return our business...

Kiniksa Reports Fourth Quarter and Full-Year 2020 Financial Results and Corporate and Pipeline Activity

Written by Customer Service on February 23, 2021. Posted in Earnings Releases And Operating Results.

– Strong execution across pipeline of immune-modulating assets throughout 2020 enables multiple milestones in 2021 –– Rilonacept in recurrent pericarditis granted priority review, with PDUFA goal date of March 21, 2021 –– Clinical data expected in 1H 2021 from KPL-404 (anti-CD40) Phase 1 clinical trial and mavrilimumab Phase 2 clinical trial in severe COVID-19 –– Year-end 2020 cash reserves of approximately $323 million –HAMILTON, Bermuda, Feb. 23, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a pipeline of assets designed to modulate immunological pathways across a spectrum of diseases, today reported fourth quarter and full-year 2020 financial results and corporate and pipeline activity.“Kiniksa delivered outstanding...

Month: February 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals